International Isotopes Inc. (INIS)
OTCMKTS: INIS · Delayed Price · USD
0.0410
-0.0020 (-4.54%)
Apr 29, 2024, 11:19 AM EDT - Market open
International Isotopes Revenue
In the year 2023, International Isotopes had annual revenue of $12.27M with 9.71% growth. Revenue in the quarter ending December 31, 2023 was $3.15M, a -0.11% decrease year-over-year.
Revenue (ttm)
$12.27M
Revenue Growth
+9.71%
P/S Ratio
1.65
Revenue / Employee
$314,548
Employees
39
Market Cap
20.28M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 12.27M | 1.09M | 9.71% |
Dec 31, 2022 | 11.18M | 1.52M | 15.73% |
Dec 31, 2021 | 9.66M | 297.05K | 3.17% |
Dec 31, 2020 | 9.36M | 409.69K | 4.57% |
Dec 31, 2019 | 8.96M | -1.41M | -13.63% |
Dec 31, 2018 | 10.37M | 2.95M | 39.73% |
Dec 31, 2017 | 7.42M | 868.24K | 13.25% |
Dec 31, 2016 | 6.55M | -510.05K | -7.22% |
Dec 31, 2015 | 7.06M | -474.66K | -6.30% |
Dec 31, 2014 | 7.54M | 687.71K | 10.04% |
Dec 31, 2013 | 6.85M | -772.78K | -10.14% |
Dec 31, 2012 | 7.62M | -1.84M | -19.45% |
Dec 31, 2011 | 9.46M | 3.35M | 54.93% |
Dec 31, 2010 | 6.11M | -15.56K | -0.25% |
Dec 31, 2009 | 6.12M | 520.40K | 9.29% |
Dec 31, 2008 | 5.60M | 911.86K | 19.44% |
Dec 31, 2007 | 4.69M | 221.05K | 4.95% |
Dec 31, 2006 | 4.47M | 1.48M | 49.71% |
Dec 31, 2005 | 2.99M | 136.59K | 4.79% |
Dec 31, 2004 | 2.85M | 778.25K | 37.59% |
Dec 31, 2003 | 2.07M | -111.11K | -5.09% |
Dec 31, 2002 | 2.18M | 3.80K | 0.17% |
Dec 31, 2001 | 2.18M | -4.10M | -65.30% |
Dec 31, 2000 | 6.28M | 2.59M | 70.13% |
Dec 31, 1999 | 3.69M | 1.68M | 83.63% |
Dec 31, 1998 | 2.01M | 1.87M | 1,379.88% |
Dec 31, 1997 | 135.77K | -664.24K | -83.03% |
Dec 31, 1996 | 800.00K | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 371.62B |
Johnson & Johnson | 85.16B |
Merck & Co. | 60.12B |
AbbVie | 54.32B |
Novartis AG | 49.92B |
AstraZeneca | 47.61B |
Thermo Fisher | 42.86B |
Abbott Laboratories | 40.11B |
INIS News
- 4 weeks ago - INTERNATIONAL ISOTOPES INC. ANNOUNCES FISCAL RESULTS FOR FISCAL YEAR 2023 - PRNewsWire
- 2 months ago - INTERNATIONAL ISOTOPES TO DIVEST DEPLETED URANIUM DECONVERSION ASSETS TO AMERICAN FUEL RESOURCES FOR $12,500,000 CASH - PRNewsWire
- 6 months ago - INTERNATIONAL ISOTOPES INC. ANNOUNCES FISCAL RESULTS FOR THE THIRD QUARTER AND FIRST NINE MONTHS OF 2023 - PRNewsWire
- 9 months ago - INTERNATIONAL ISOTOPES INC. ANNOUNCES FISCAL RESULTS FOR THE SECOND QUARTER AND FIRST SIX MONTHS OF 2023 - PRNewsWire
- 10 months ago - INTERNATIONAL ISOTOPES INC. ANNOUNCES CHANGES IN EXECUTIVE OFFICERS AND DIRECTORS - PRNewsWire
- 11 months ago - INTERNATIONAL ISOTOPES INC. ANNOUNCES THE ACQUISITION OF THE AMICI INC. - PRNewsWire
- 1 year ago - INTERNATIONAL ISOTOPES INC. ANNOUNCES FINANCIAL RESULTS FOR THE FIRST QUARTER 2023 - PRNewsWire
- 1 year ago - INTERNATIONAL ISOTOPES INC. ANNOUNCES THE APPOINTMENT OF SHAHE BAGERDJIAN AS PRESIDENT - PRNewsWire